Robotic pancreatoduodenectomy has matured past its experimental phase, and randomized trials support it as a safe alternative to open surgery. Its results still depend on surgeon experience and institutional volume.
- Randomized trials show shorter length of stay, with morbidity noninferior to open pancreatoduodenectomy.
- Oncologic outcomes are similar to open pancreatoduodenectomy.
Where it fits: Robotic pancreatoduodenectomy is reasonable in centers with experienced surgeons and high procedural volume. Wider adoption should come with structured training, mentorship, and outcomes reporting, because results in less experienced hands have not been shown to match these data.
Review by May MC, Russell A and Hogg ME in Am J Surg
Copyright © 2026 Elsevier Inc. All rights reserved.